Images
Participants
Contact
Various media have published the discovery made by the team led by Ferran Azorín, group leader at IRB Barcelona and CSIC research professor, and recently published in the journal Nature Communications. This laboratory has found that the dDsk2 protein, in addition to degrading proteins, also plays a key role in regulating gene expression. Ferran Azorín’s group will start a study on the relationship between dDsk2 mutations and neurodegenerative diseases, such as Alzheimer’s disease.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
